The vaccine is experimental and the full safety profile is still being discovered. The EUA specially requires that there is "no adequate, approved, and available alternatives". The conclusion: "large reductions in COVID-19 deaths are possible using ivermectin" suggests it may be a viable alternative to widescale deployment of a vaccine that did not go through the full approval process.